Subscribe To
Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors
BOSTON, July 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the appointment of Anthony M. Manning, Ph.D., to its Board of Directors. Dr. Manning is a highly accomplished drug discovery leader in the field of autoimmune and inflammatory […] The post Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors appeared first on ForexTV...
Read More
Posted: Jul 26 2023, 11:30
Author Name: forextv
Views: 080862